Stockscreener 앱 받기
0.8701
19.44%
-0.2099
전일 마감가:
$1.08
열려 있는:
$1.03
하루 거래량:
243.56K
Relative Volume:
4.25
시가총액:
$15.54M
수익:
-
순이익/손실:
$-21.91M
주가수익비율:
-0.584
EPS:
-1.49
순현금흐름:
-
1주 성능:
-31.49%
1개월 성능:
-58.57%
6개월 성능:
-47.58%
1년 성능:
-78.67%
1일 변동 폭
$0.8201
$1.1481
1주일 범위
$0.8201
$1.30
52주 변동 폭
$0.8201
$4.65
Incannex Healthcare Inc Stock (IXHL) Company Profile
명칭
Incannex Healthcare Inc
전화
61 409 840 786
주소
401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA
IXHL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.8701 | 15.54M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
170.37 | 76.29B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.17 | 47.88B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.45 | 47.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.36 | 17.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.24 | 13.95B | 612.78M | -86.37M | -62.91M | -0.87 |
Incannex Healthcare Inc 주식(IXHL)의 최신 뉴스
Incannex Healthcare Inc. Announces Pricing Of $12.5 Million Private Placement Priced At The Market Under Nasdaq Rules - Marketscreener.com
Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - The Manila Times
Can This $12.5M Deal Push Incannex's Sleep Apnea Treatment to Phase 3? - StockTitan
IXHL stock touches 52-week low at $1.09 amid market challenges - Investing.com UK
Incannex OSA Drug Candidate IHL-42X Sails Through Milestones - Sleep Review
IXHL stock touches 52-week low at $1.49 amid market challenges By Investing.com - Investing.com South Africa
IXHL stock touches 52-week low at $1.49 amid market challenges - Investing.com UK
Incannex Healthcare Limited Reports Quarterly Financials - TipRanks
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025 - The Kingston Whig-Standard
Biotech Earnings Alert: Incannex Secures $50M Financing as R&D Costs Drop 46% - StockTitan
Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates - Defense World
Incannex Healthcare Reports Fiscal Second Quarter Results -February 14, 2025 at 08:49 am EST - Marketscreener.com
Incannex Healthcare Inc. SEC 10-Q Report - TradingView
Incannex Healthcare Appoints Alison Wimms, Ph.D. to its Newly Formed IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Defense World
Incannex Forms Clinical Advisory Board to Guide IHL-42X Sleep Apnea Drug Development - Sleep Review
Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board - The Manila Times
Incannex Healthcare Inc. Announces the Appointment of Alison Wimms as an Advisor to Its Newly Formed Ihl-42X Obstructive Sleep Apnea Clinical Advisory Board - Marketscreener.com
Sleep Medicine Pioneer Joins Incannex's Revolutionary OSA Treatment Development - StockTitan
Incannex Healthcare Announces Positive Topline Results from PK Study - Defense World
Incannex Reports Positive Data for OSA Drug Candidate IHL-42X - Sleep Review
Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea - The Manila Times
Incannex Reports Strong Results for Sleep Apnea Drug IHL-42X in Key Clinical Study - StockTitan
Incannex Healthcare faces Nasdaq delisting over market value By Investing.com - Investing.com South Africa
Incannex Healthcare faces Nasdaq delisting over market value - Investing.com
Reviewing Alterity Therapeutics (NASDAQ:ATHE) and Incannex Healthcare (NASDAQ:IXHL) - Defense World
IXHLIncannex Healthcare Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
Incannex Healthcare Inc. Receives Notice of Listing Deficiency from NasdaqOn January 3, 2025, Incannex Healthcare Inc. (NASDAQ: IXHL) received a written notice from The Nasdaq Stock Market LLC stating that the company is not in compliance with Nasda - Defense World
U.S. Energy (NASDAQ:USEG) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Financial Security Advisor Inc. Has $12.95 Million Position in Microsoft Co. (NASDAQ:MSFT) - Defense World
Incannex Healthcare secures shareholder approvals at annual meeting By Investing.com - Investing.com Canada
Incannex Healthcare secures shareholder approvals at annual meeting - Investing.com
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025 - Nanton News
Incannex Completes Key FDA Trial Phase, Advances Anxiety Drug Development | IXHL Stock News - StockTitan
Incannex Healthcare (IXHL) & Its Rivals Critical Review - Defense World
Incannex Healthcare Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com
Incannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% – Still a Buy? - Defense World
Incannex Healthcare (NASDAQ:IXHL) Trading Up 5.5%What's Next? - MarketBeat
Incannex Healthcare Reports Q3 Loss, Secures New Funding - TipRanks
RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up - Seeking Alpha
Incannex Healthcare Inc (IXHL) Quarterly 10-Q Report - Quartzy
Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Incannex Secures $59M Financing, Reports Q1 Results Amid Clinical Trial Progress | IXHL Stock News - StockTitan
Incannex Healthcare names Lou Barbato as chief medical officer - MSN
Incannex appoints new chief medical officer - Investing.com India
Incannex appoints new chief medical officer By Investing.com - Investing.com South Africa
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewswire
Incannex Healthcare Appoints Dr. Barbato as CMO - TipRanks
Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks - Simply Wall St
Incannex Healthcare secures $3.3 million through debt financing By Investing.com - Investing.com Australia
Incannex Healthcare secures $3.3 million through debt financing - Investing.com
Incannex Healthcare Inc (IXHL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.86%
0.87%
자본화:
|
볼륨(24시간):